Ave Maria Biotech, Inc.-preview

Avemariabiotech

Ave Maria Biotech, Inc.

Private

FloridaHealthcare & Life Scienceshttps://avemariabiotech.com/

Last Round

M&A

Aug 1, 2025

Total Funding Raised

$4.62M

Company Overview

Ave Maria Biotech, Inc. is a healthcare technology company that developed the BD-500, a device for real-time detection of airborne pathogens.

Sector

Healthcare & Life Sciences

Verticals

Sensors, Biotech Equipment, Defense Tech, Environmental Monitoring, Health IoT

Business Model

B2G

Customer Profile

Hardware Sales, Government Contracts, Hardware + Subscription

AI Layer

Non-AI

Keywords

airborne pathogen detectionreal-time detectionpathogen sensorbiodefensebiosurveillancephotonics sensorCooperative Research and Development AgreementCRADAdefense techhealth IoTbiotech equipmentenvironmental monitoringgovernment contracts

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ave Maria Biotech, Inc. Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Ave Maria Biotech, Inc. Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
M&A	Aug 1, 2025
Grant	Oct 9, 2023
Grant	Aug 25, 2022
Grant	Jun 14, 2022
Grant	Apr 5, 2022
Grant	Jun 11, 2020

View all Funding Rounds

Ave Maria Biotech, Inc. Investors

Notable investors and investment history

Investor	Rounds
AI Technology Group Inc.	M&A
National Cancer Institute	Grant
NIH RADx	Grant
Life Science Washington Institute	Grant
National Institute of Diabetes and Digestive and Kidney Diseases	Grant
America's Seed Fund	Grant
Washington State Department of Commerce	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Aug 1, 2025
$14M round led by AI Technology Group Inc.
Oct 9, 2023
$25K grant received from Life Science Washington Institute and Washington State Department of Commerce.

View all signals

Ave Maria Biotech, Inc. Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Ave Maria Biotech, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ave Maria Biotech, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersFlorida

Year FoundedN/A

Last FundingAug 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.